AstraZeneca (cancer drug) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

AstraZeneca (cancer drug) General Information

Description

Cancer drug of AstraZenca. The drug, Caprelsa is used for the treatment of aggressive and symptomatic medullary thyroid carcinoma.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • London
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AstraZeneca (cancer drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AstraZeneca (cancer drug)‘s full profile, request access.

Request a free trial

AstraZeneca (cancer drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AstraZeneca (cancer drug)‘s full profile, request access.

Request a free trial